ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive.

Pedro Isaacsson Velho et al.PubMed ↗Publisher ↗

No numbers read from the abstract.